Lemonaid Health Review

Lemonaid Health — Provider Profile

Overview

Lemonaid Health is a cash-pay telehealth platform founded in 2013 that offers GLP-1 medications for weight loss alongside primary care and mental health services. The company has had a turbulent ownership history: acquired by 23andMe for $400 million in 2021, then sold to Bambu Ventures for just $10 million in 2025 after 23andMe's Chapter 11 bankruptcy filing. The 97.5% value destruction raises legitimate questions about long-term platform stability.

April 2026 context: This provider is active and prescribing brand-name GLP-1 medications. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending; not yet in effect. Compounded semaglutide supply is declining under FDA enforcement pressure.

Despite the ownership turmoil, Lemonaid offers one of the broader medication menus in the GLP-1 telehealth space — compounded and brand-name options for both semaglutide and tirzepatide, plus a Zepbound vial integration through LillyDirect.

Medications Offered

• Compounded semaglutide + B12 — Weekly subcutaneous injection with added vitamin B12
• Compounded semaglutide microdoses — Lower-dose entry option
• Compounded tirzepatide — Weekly subcutaneous injection
• Compounded tirzepatide microdoses — Lower-dose entry option
• Brand Ozempic (semaglutide) — Cash-pay through Lemonaid pharmacy
• Brand Wegovy (semaglutide) — Cash-pay through Lemonaid pharmacy
• Brand Wegovy HD (semaglutide 7.2mg) — Higher-dose Wegovy formulation, weekly subcutaneous injection
• Orforglipron (oral GLP-1) — Daily oral GLP-1 receptor agonist, $149/mo
• Brand Zepbound vials (tirzepatide) — Fulfilled via LillyDirect partnership
• Metformin — Oral adjunct, often used alongside GLP-1s

Pricing

All medication prices are in addition to a required $49/month membership fee.

True monthly cost (membership + medication):

• Cheapest compounded option: $248/mo (microdose semaglutide or tirzepatide)
• Standard compounded (3-month plan): $298/mo
• Standard compounded (month-to-month): $348/mo

This puts Lemonaid significantly above budget competitors like Ro ($149/mo) and Henry Meds ($149/mo), and notably above Hims ($199/mo). The two-part pricing structure (membership + medication) makes the true cost less obvious.

States Served

Lemonaid Health's weight loss program is not available in all 50 states. The company does not publish a specific state list — patients must check eligibility during signup. Lab testing (included annually) is specifically unavailable in New York, New Jersey, Rhode Island, and Hawaii.

Insurance

No insurance accepted. Lemonaid is entirely cash-pay for membership, medications, and consultations. Patients can request that a prescription be sent to an outside pharmacy where insurance may apply, but the Lemonaid platform itself processes no insurance claims.

Consultation Process

Model: Primarily async, with video/phone when clinically required.

1. Complete an online health intake questionnaire
2. A licensed clinician reviews your submission (typically within 24 hours)
3. Provider follows up with questions or schedules a live video/phone call if needed (some states mandate live consultations)
4. If approved, compounded medication ships directly; Zepbound routes through LillyDirect
5. Regular check-ins during dose adjustments, with ongoing provider messaging

Most patients will not have a live consultation — the default is async questionnaire-based care.

What's Included

Included in $49/month membership:

• Clinician consultation and ongoing provider messaging
• Personalized treatment recommendations
• One annual lab order at Quest Diagnostics (metabolism biomarkers)
• Free discreet shipping on compounded medications
• No charge for dosage changes on the same medication

Not included:

• Lifestyle or behavioral coaching (no nutrition education, exercise guidance, or behavioral health support)
• Additional lab work beyond the annual order
• Lab testing in NY, NJ, RI, or HI

Pros

• Broad medication menu: compounded and brand-name, semaglutide and tirzepatide
• Zepbound vial integration via LillyDirect — unique among many competitors
• Annual lab testing included (most budget competitors skip this)
• Microdose options provide a lower-cost entry point
• Multi-month commitment discounts available
• No long-term contract required

Cons

• Expensive. The $49/month membership on top of medication costs makes effective pricing $248-$348/month — significantly more than Ro, Henry Meds, or Hims
• No insurance accepted for any services
• No coaching or behavioral support — medication-only model
• Ownership instability. From 23andMe's $400M acquisition to a $10M fire sale in under 4 years. New ownership by a small VC firm means uncertain long-term stability
• $3.25M privacy settlement over pixel tracking that shared patient health data with Facebook and Google without consent
• Not available in all 50 states with no published availability list
• Brand-name medications are extremely expensive through Lemonaid compared to using insurance at a local pharmacy

Best For

Patients who want both semaglutide and tirzepatide options (compounded and brand-name) from a single platform, and who value the included annual lab testing. The Zepbound vial option via LillyDirect is a genuine differentiator for patients specifically seeking brand-name tirzepatide at a competitive cash-pay price.

Editorial Verdict

Lemonaid Health offers one of the most complete GLP-1 medication menus in telehealth — but the value proposition is hard to justify for most patients. At $248-$348/month effective cost for compounded medications, you're paying 65-130% more than Ro or Henry Meds ($149/month) without getting meaningfully more clinical depth. The annual lab order is a nice inclusion, but doesn't close that gap.

The ownership history is a real concern. Going from a $400 million acquisition to a $10 million distressed sale in four years, combined with a privacy class action settlement, should give patients pause — especially when trusting a platform with sensitive health data. The new Bambu Ventures ownership is unproven in healthcare.

If you specifically want the LillyDirect Zepbound vial option or need both semaglutide and tirzepatide compounded options on one platform, Lemonaid is worth considering. For most patients seeking straightforward compounded GLP-1 access, there are cheaper and more established alternatives.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• Cheapest GLP-1 Providers — Budget options compared
• GLP-1 Cost & Insurance FAQ — What you'll actually pay
• Compounded vs Brand GLP-1 FAQ — Safety and efficacy differences